The Complement and Coagulation Cascades Pathway is Associated with Acute Necrotizing Pancreatitis by Genomics and Proteomics Analysis

References

• Forsmark CE, Campion EW, Swaroop Vege S, Wilcox CM. Acute pancreatitis. N Engl J Med. 2016;375(20):1972–1981. doi:10.1056/NEJMra1505202
   PubMed Web of Science ®Google Scholar
• Schepers NJ, Bakker OJ, Besselink MG, et al. Impact of characteristics of organ failure and infected necrosis on mortality in necrotising pancreatitis. Gut. 2019;68(6):1044–1051. doi:10.1136/gutjnl-2017-314657
   PubMed Web of Science ®Google Scholar
• Trikudanathan G, Wolbrink DRJ, van Santvoort HC, Mallery S, Freeman M, Besselink MG. Current concepts in severe acute and necrotizing pancreatitis: an evidence-based approach. Gastroenterology. 2019;156(7):1994–2007 e1993. doi:10.1053/j.gastro.2019.01.269
   PubMed Web of Science ®Google Scholar
• Chua TY, Walsh RM, Baker ME, Stevens T. Necrotizing pancreatitis: diagnose, treat, consult. Cleve Clin J Med. 2017;84(8):639–648. doi:10.3949/ccjm.84a.16052
   PubMed Web of Science ®Google Scholar
• Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute pancreatitis: value of CT in establishing prognosis. Radiology. 1990;174(2):331–336. doi:10.1148/radiology.174.2.2296641
   PubMed Web of Science ®Google Scholar
• Boxhoorn L, Voermans RP, Bouwense SA, et al. Acute pancreatitis. Lancet. 2020;396(10252):726–734. doi:10.1016/S0140-6736(20)31310-6
   PubMed Web of Science ®Google Scholar
• Hansen SEJ, Madsen CM, Varbo A, Tybjaerg-Hansen A, Nordestgaard BG. Genetic variants associated with increased plasma levels of triglycerides, via effects on the lipoprotein lipase pathway, increase risk of acute pancreatitis. Clin Gastroenterol Hepatol. 2020;19:1652–1660.e6. doi:10.1016/j.cgh.2020.08.016
   PubMed Web of Science ®Google Scholar
• Whitcomb DC, LaRusch J, Krasinskas AM, et al. Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. Nat Genet. 2012;44(12):1349–1354. doi:10.1038/ng.2466
   PubMed Web of Science ®Google Scholar
• Whitcomb DC. Genetic risk factors for pancreatic disorders. Gastroenterology. 2013;144(6):1292–1302. doi:10.1053/j.gastro.2013.01.069
   PubMed Web of Science ®Google Scholar
• Barreto SG, Habtezion A, Gukovskaya A, et al. Critical thresholds: key to unlocking the door to the prevention and specific treatments for acute pancreatitis. Gut. 2021;70(1):194–203. doi:10.1136/gutjnl-2020-322163
   PubMed Web of Science ®Google Scholar
• Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis–2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–111. doi:10.1136/gutjnl-2012-302779
   PubMed Web of Science ®Google Scholar
• Schmidt J, Rattner DW, Lewandrowski K, et al. A better model of acute pancreatitis for evaluating therapy. Ann Surg. 1992;215(1):44–56. doi:10.1097/00000658-199201000-00007
   PubMed Web of Science ®Google Scholar
• Berends ET, Kuipers A, Ravesloot MM, Urbanus RT, Rooijakkers SH. Bacteria under stress by complement and coagulation. FEMS Microbiol Rev. 2014;38(6):1146–1171. doi:10.1111/1574-6976.12080
   PubMed Web of Science ®Google Scholar
• Hartwig W, Klafs M, Kirschfink M, et al. Interaction of complement and leukocytes in severe acute pancreatitis: potential for therapeutic intervention. Am J Physiol Gastrointest Liver Physiol. 2006;291(5):G844–850. doi:10.1152/ajpgi.00016.2006
   PubMed Web of Science ®Google Scholar
• Linders J, Madhi R, Morgelin M, King BC, Blom AM, Rahman M. Complement component 3 is required for tissue damage, neutrophil infiltration, and ensuring NET formation in acute pancreatitis. Eur Surg Res. 2020;61(6):163–176. doi:10.1159/000513845
   PubMed Web of Science ®Google Scholar
• Seelig R, Lankisch PG, Koop H, Winckler K, Kaboth U, Seelig HP. Complement system in sodium taurocholate pancreatitis in the rat. Res Exp Med (Berl). 1978;174(1):57–65. doi:10.1007/BF01851939
   PubMedGoogle Scholar
• Zhang L, Qiao Z, Feng H, Shen J. The early predictive role of complement C3 and C4 in patients with acute pancreatitis. J Clin Lab Anal. 2020;34(5):e23205. doi:10.1002/jcla.23205
   PubMed Web of Science ®Google Scholar
• Merza M, Hartman H, Rahman M, et al. Neutrophil extracellular traps induce trypsin activation, inflammation, and tissue damage in mice with severe acute pancreatitis. Gastroenterology. 2015;149(7):1920–1931 e1928. doi:10.1053/j.gastro.2015.08.026
   PubMed Web of Science ®Google Scholar
• Sim RB, Day AJ, Moffatt BE, Fontaine M. Complement factor I and cofactors in control of complement system convertase enzymes. Methods Enzymol. 1993;223:13–35.
   PubMed Web of Science ®Google Scholar
• Brown EJ. Complement receptors and phagocytosis. Curr Opin Immunol. 1991;3(1):76–82. doi:10.1016/0952-7915(91)90081-B
   PubMed Web of Science ®Google Scholar
• Roxvall L, Bengtson A, Sennerby L, Heideman M. Activation of the complement cascade by trypsin. Biol Chem Hoppe Seyler. 1991;372(4):273–278. doi:10.1515/bchm3.1991.372.1.273
   PubMed Web of Science ®Google Scholar
• Travis J, Salvesen GS. Human plasma proteinase inhibitors. Annu Rev Biochem. 1983;52:655–709. doi:10.1146/annurev.bi.52.070183.003255
   PubMed Web of Science ®Google Scholar
• Roberts RC. Protease inhibitors of human plasma. Alpha-2-macroglobulin. J Med. 1985;16(1–3):129–224.
   PubMedGoogle Scholar
• Balldin G, Eddeland A, Ohlsson K. Studies on the role of the plasma protease inhibitors on in vitro C3 activation and in acute pancreatitis. Scand J Gastroenterol. 1981;16(5):603–609. doi:10.3109/00365528109182018
   PubMed Web of Science ®Google Scholar
• Ohlsson K. Elimination of 125-I-trypsin alpha-macroglobulin complexes from blood by reticuloendothelial cells in dogs. Acta Physiol Scand. 1971;81(2):269–272. doi:10.1111/j.1748-1716.1971.tb04900.x
   PubMedGoogle Scholar
• Lasson Å, Ohlsson K. Protease inhibitors in acute human pancreatitis. Scand J Gastroenterol. 2018;19(6):779–786. doi:10.1080/00365521.1984.12005808
   Web of Science ®Google Scholar
• Buchler M, Malfertheiner P, Schoetensack C, Uhl W, Beger HG. Sensitivity of antiproteases, complement factors and C-reactive protein in detecting pancreatic necrosis. Results of a prospective clinical study. Int J Pancreatol. 1986;1(3–4):227–235. doi:10.1007/BF02795248
   PubMedGoogle Scholar
• Wilson C, Heads A, Shenkin A, Imrie CW. C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis. Br J Surg. 1989;76(2):177–181. doi:10.1002/bjs.1800760224
   PubMed Web of Science ®Google Scholar
• Ohlsson K, Laurell CB. The disappearance of enzyme-inhibitor complexes from the circulation of man. Clin Sci Mol Med. 1976;51(1):87–92. doi:10.1042/cs0510087
   PubMedGoogle Scholar
• Balldin G, Ohlsson K. Demonstration of pancreatic protease-antiprotease complexes in the peritoneal fluid of patients with acute pancreatitis. Surgery. 1979;85(4):451–456.
   PubMed Web of Science ®Google Scholar
• Serna M, Giles JL, Morgan BP, Bubeck D. Structural basis of complement membrane attack complex formation. Nat Commun. 2016;7:10587. doi:10.1038/ncomms10587
   PubMed Web of Science ®Google Scholar
• Dudkina NV, Spicer BA, Reboul CF, et al. Structure of the poly-C9 component of the complement membrane attack complex. Nat Commun. 2016;7:10588. doi:10.1038/ncomms10588
   PubMed Web of Science ®Google Scholar
• Tjernberg J, Ekdahl KN, Lambris JD, Korsgren O, Nilsson B. Acute antibody-mediated complement activation mediates lysis of pancreatic islets cells and may cause tissue loss in clinical islet transplantation. Transplantation. 2008;85(8):1193–1199. doi:10.1097/TP.0b013e31816b22f3
   PubMed Web of Science ®Google Scholar
• Tegla CA, Cudrici C, Patel S, et al. Membrane attack by complement: the assembly and biology of terminal complement complexes. Immunol Res. 2011;51(1):45–60. doi:10.1007/s12026-011-8239-5
   PubMed Web of Science ®Google Scholar
• Walport MJ, Mackay IR, Rosen FS. Complement. First of two parts. N Engl J Med. 2001;344(14):1058–1066. doi:10.1056/NEJM200104053441406
   PubMed Web of Science ®Google Scholar
• Walport MJ, Mackay IR, Rosen FS. Complement. Second of two parts. N Engl J Med. 2001;344(15):1140–1144. doi:10.1056/NEJM200104123441506
   PubMed Web of Science ®Google Scholar
• Martinez RJ, Carroll SF. Sequential metabolic expressions of the lethal process in human serum-treated Escherichia coli: role of lysozyme. Infect Immun. 1980;28(3):735–745. doi:10.1128/iai.28.3.735-745.1980
   PubMed Web of Science ®Google Scholar
• Glynn AA, Milne CM. Lysozyme and immune bacteriolysis. Nature. 1965;207(5003):1309–1310. doi:10.1038/2071309a0
   PubMed Web of Science ®Google Scholar
• Triantafilou K, Hughes TR, Triantafilou M, Morgan BP. The complement membrane attack complex triggers intracellular Ca2+ fluxes leading to NLRP3 inflammasome activation. J Cell Sci. 2013;126(Pt 13):2903–2913. doi:10.1242/jcs.124388
   PubMed Web of Science ®Google Scholar
• Xie CB, Qin L, Li G, et al. Complement membrane attack complexes assemble NLRP3 inflammasomes triggering IL-1 activation of IFN-gamma-primed human endothelium. Circ Res. 2019;124(12):1747–1759. doi:10.1161/CIRCRESAHA.119.314845
   PubMed Web of Science ®Google Scholar
• Xie CB, Jane-Wit D, Pober JS. Complement membrane attack complex: new roles, mechanisms of action, and therapeutic targets. Am J Pathol. 2020;190(6):1138–1150. doi:10.1016/j.ajpath.2020.02.006
   PubMed Web of Science ®Google Scholar
• den Dunnen JT, Dalgleish R, Maglott DR, et al. HGVS recommendations for the description of sequence variants: 2016 update. Hum Mutat. 2016;37(6):564–569. doi:10.1002/humu.22981
   PubMed Web of Science ®Google Scholar